Archive for July 2023
Immunexpress Announces Adoption of SeptiCyte® RAPID by FirstHealth of the Carolinas
SEATTLE and BRISBANE, Australia, July 20, 2023 /PRNewswire/ — Immunexpress, Pty Ltd., a molecular diagnostic company focused on improving outcomes for patients suspected of sepsis, announced today the adoption of SeptiCyte® RAPID by FirstHealth of the Carolinas, a non-profit health system licensed for four hospitals in Pinehurst, Troy, Rockingham and Raeford, North Carolina. SeptiCyte RAPID will be available at FirstHealth as a tool in differentiating…
Read MoreSlice of Healthcare’s Big Breakthrough podcast features Richard Brandon, Chief Scientific Officer At Immunexpress
From the Slice of Healthcare podcast notes: What you’ll get out of this episode: Richard’s background Overview of Immunexpress The impact of a lack of reliable sepsis diagnostics SeptiCyte technology What’s next?
Read More